Reblozyl 25 MG vials
Ended Awarded
- Contract number
- SPE2DB25FQ0L1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,160
Award facts
- Contract value 100% obligated
- $13,159.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,159.85 to AmerisourceBergen Drug Corp for Reblozyl 25 mg vials, with completion targeted for September 18, 2025. This firm fixed-price contract, awarded August 27, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Reblozyl is a specialized erythroid maturation agent used in treating certain forms of anemia, reflecting the Defense Health System's procurement of pharmaceutical specialty medications to support military healthcare operations.
This delivery order is a child contract issued under AmerisourceBergen's substantial $999.9 billion DLA Troop Support Medical IDC (SPE2DX), which extends through December 2026 and provides comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, maintains a significant federal contracting portfolio supplying medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award demonstrates the company's continued role as a critical vendor within DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FQ0L1?
SPE2DB25FQ0L1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FQ0L1 worth?
The government has obligated $13,160 on SPE2DB25FQ0L1.
Is contract SPE2DB25FQ0L1 an order under another contract?
Yes. SPE2DB25FQ0L1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0L1 competed?
The extent of competition for SPE2DB25FQ0L1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award